SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (5673)11/16/1998 9:28:00 PM
From: corporal spewchunks  Read Replies (1) | Respond to of 6136
 
Interleukin II just mentioned favorably by Dan Rather on the CBS Evening News as a potential AID's treatment.



To: Biomaven who wrote (5673)11/19/1998 11:22:00 AM
From: billkirn  Read Replies (1) | Respond to of 6136
 
Peter S: Thanks for the link. Note that Vical has recently demonstrated success in facilitating the body to produce IL-2 via DNA injection.
biz.yahoo.com

Down stream, if the IL-2 studies show significance for AIDS treatment, Vical's contribution could be very important.
Agouron is on a roll so let us enjoy these good times.

Here! Here! to the long term investor.
Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News